Insider Transactions in Q3 2019 at Spring Works Therapeutics, Inc. (SWTX)
Insider Transaction List (Q3 2019)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 17
2019
|
Orbimed Advisors LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
275,000
+3.58%
|
$4,950,000
$18.0 P/Share
|
|
Sep 17
2019
|
Orbimed Advisors LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
7,131,307
+31.43%
|
-
|
|
Sep 17
2019
|
Bain Capital Life Sciences Investors, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
150,000
+2.02%
|
$2,700,000
$18.0 P/Share
|
|
Sep 17
2019
|
Bain Capital Life Sciences Investors, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
7,131,307
+31.43%
|
-
|
|
Sep 17
2019
|
Pfizer Inc > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
50,000
+1.08%
|
$900,000
$18.0 P/Share
|
|
Sep 17
2019
|
Pfizer Inc > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
4,543,847
+34.48%
|
-
|